The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen

Brain, Behavior, and Immunity

Volumn 16, Issue 5, 2002, Pages 596-601

  Lestage, J ^a   Verrier, D ^a   Palin, K ^a   Dantzer, R ^a  

^a INSERM   (France)

Author keywords

Brain; Cytokine; Indoleamine 2,3 dioxygenase; Interferon ; Lipopolysaccharide; Mouse; Superantigen

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; ESSENTIAL AMINO ACID; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; SEROTONIN; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN; TRYPTOPHAN; LIPOPOLYSACCHARIDE; TRYPTOPHAN 2,3 DIOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INDUCTION; IMMUNOSTIMULATION; MALE; MOOD; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; BRAIN; ENZYMOLOGY; METABOLISM;

ANIMALS; BRAIN; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; SUPERANTIGENS; TRYPTOPHAN; TRYPTOPHAN OXYGENASE;

EID: 0036429151     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-1591(02)00014-4     Document Type: Conference Paper

References (33)

1. Balkhy, H. H., & Heinzel, P. P. (1999). Endotoxin fails to induce IFN-γ in endotoxin-tolerant mice: Deficiencies in both IL-12 heterodimer production and IL-12 responsiveness. J. Immunol., 162, 3633-3638.
2. Block, M. I., Berg, M., McNamara, M. J., Norton, J. A., Fraker, D. L., & Alexander, H. R. (1993). Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia. J. Exp. Med., 178, 1085-1090.
3. Byrne, G. I., Lehmann, L. K., Kirschbaum, J. G., Borden, B. C., Lee, C. M., & Brown, R. R. (1986). Induction of tryptophan degradation in vitro and in vivo: A γ-interferon- stimulated activity. J. Interferon Res., 6, 389-396.
4. Capuron, L., Ravaud, A., Neveu, P.J., Miller, A.H., Maes, M., Dantzer, R. (2002). Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol. Psychiat., 7, 468-473.
5. Dale, W. E., Dang, Y., & Brown, O. R. (2000). Tryptophan metabolism through the kynurenine pathway in rat brain and liver slices. Free Radio. Biol. Med., 29, 191-198.
6. Dantzer, R. (2001). Cytokines and sickness behavior: Where do we stand? Brain Behav. Immun., 15, 7-24.
7. Fernstrom, J. D., & Wurtman, R. J. (1971a). Brain serotonin content: Physiological dependence on plasma tryptophan levels. Science, 173, 149-152.
8. Fernstrom, J. D., & Wurtman, R. J. (1971b). Brain serotonin content: Increase following ingestion of carbohydrate diet. Science, 174, 1023-1025.
9. Fujigaki, S., Saito, K., Fujii, H., Wada, H., Noma, A., & Seishima, M. (1999). Quantification of anthranilic acid and its related enzyme activity in several different species. Adv. Exp. Med., 461, 625-628.
10. Fujigaki, S., Saito, K., Sesikawa, K., Tone, S., Takikawa, O., Fujii, H., Wada, H., Noma, A., & Seishima, M. (2001). Lipopolysaccharide induction of indole-amine 2,3-dioxygenase is mediated dominantly by an IFN-γ-independent mechanism. Eur. J. Immunol., 31, 2313-2318.
11. Fujigaki, S., Saito, K., Takemura, M., Fujii, H., Wada, H., Noma, A., & Seishima, M. (1998). Species difference in L-tryptophan-kynurenine pathway metabolism: Quantification of anthranilic acid and its related enzymes. Arch. Biochem. Biophys., 358, 329-335.
12. Heinzel, F. P. (1990). The role of IFN-γ in the pathology of experimental endotoxemia. J. Immunol., 145, 2920-2924.
13. Heninger, G. R. (1995). Indoleamines: The role of serotonin in clinical disorders. In F. E. Bloom, & D. J. Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress (pp. 471-482). New York: Raven Press.
14. Heremans, H., Dijkmans, R., Sobis, H., Vandekerckhove, F., & Billiau, A. (1987). Regulation by interferons of the local inflammatory response to bacterial lipopolysaccharide. J. Immunol., 138, 4175-4179.
15. Heyes, M. P., Saito, K., Chen, C. Y., Proescholdt, M. G., Nowak, T. S., Li, J., Beagles, K., Proescholdt, M. A., Zito, M. A., Kawai, K., & Markey, S. P. (1997). Species heterogeneity between gerbils and rats: Quinolinate production by microglia and astrocytes and accumulations in response to ischemic brain injury and systemic immune activation. J. Neurochem., 69, 1519-1529.
16. Heyes, M. P., Quearry, B. J., & Markey, S. P. (1989). Systemic endotoxin increases L-tryptophan, 5-hydroxyindolacetic acid, 3-hydroxykynurenin and quinolinic acid content of mouse cerebral cortex. Brain Res., 491, 173-179.
17. Holmes, E. W. (1988). Determination of serum kynurenine and hepatic tryptophan dioxygenase activity by high-performance liquid chromatography. Anal. Biochem., 172, 518-525.
18. Jupin, C., Anderson, S., Damais, C., Alouf, J. E., & Parant, M. (1988). Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and γ-interferon. J. Exp. Med., 167, 752-761.
19. Muchamuel, T., Menon, S., Pisacane, P., Howard, M. C., & Cockayne, D. A. (1997). IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia. J. Immunol., 158, 2898-2903.
20. Murr, C., Widner, B., Gerlach, D., Werner-Felmayer, G., Dierich, M. P., Wachter, H, & Fuchs, D. (1997). Streptococcal erythrogenic toxins induce tryptophan degradation in human peripheral blood mononuclear cells. Int. Arch. Allergy Immunol., 114, 224-228.
21. Nagaki, M., Muto, Y., Ohnishi, H., Yasuda, S., Sano, K., Naito, T., Maeda, T., Yamada, T., & Moriwaki, H. (1994). Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B. Gastroenterology, 106, 450-458.
22. Saito, K., Markey, S. P., & Heyes, M. P. (1991). Chronic effects of γ-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice. Brain Res., 546, 151-154.
23. Saito, K., Markey, S. P., & Heyes, M. P. (1992). Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Neuroscience, 51, 25-39.
24. Saito, K., Crowley, J. S., Markey, S. P., & Heyes, M. P. (1993a). A mechanism for increased quinolinic acid formation following acute systemic immune stimulation. J. Biol. Chem., 268, 15496-15503.
25. Saito, K., Nowak, T. S., Suyama, K., Quearry, B. J., Saito, M., Crowley, J. S., Markey, S. P., & Heyes, M. P. (1993b). Kynurenine pathway enzymes in brain: Responses to ischemic brain injury versus systemic immune activation. J. Neurochem., 61, 2061-2070.
26. Sanni, L. A., Thomas, S. R., Tattam, B. N., Moore, D. E., Chaudhri, G., Stacker, R., & Hunt, N. H. (1998). Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Am. J. Pathol., 752, 611-619.
27. Schumann, J., Bluethmann, H., & Tiegs, G. (2000). Synergism of Pseudomonas aeruginosa exotoxin A with endotoxin, superantigen, or TNF results in TNFR1- and TNFR2-dependent liver toxicity in mice. Immunol. Lett., 74, 165-172.
28. Sono, M. (1989). The roles of superoxide anion and methylene blue in the reductive activation of indoleamine 2,3-dioxygenase by ascorbic acid or by xanthine oxidase-hypoxanthine. J. Biol. Chem., 264, 1616-1622.
29. Takikawa, O., Koroiwa, T., Yamazaki, F., & Kido, R. (1988). Mechanism of interferon-γ action. J. Biol. Chem., 263, 2041-2048.
30. Taylor, M. W., & Feng, G. (1991). Relationship between interferon-γ, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J., 5, 2516-2522.
31. Thomas, S. R., Mohr, D., & Stacker, R. (1994). Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-γ primed mononuclear phagocytes. J. Biol. Chem., 269, 14457-14464.
32. Villavedra, M., Carol, H., Hjulström, M., Holmgren, J., & Czerkinsky, C. (1997). "PERFEXT": A direct method for quantitative assessment of cytokine production in vivo at the local level. Res. Immunol., 148, 257-266.
33. Weiss, G., Murr, C., Zoller, H., Haun, M., Widner, B., Ludescher, C., & Fuchs, D. (1999). Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells. Clin. Exp. Immunol., 116, 435-440.